TCL Archive Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum January 8, 1993
TCL Archive NIH Consensus Conference Concludes That MRI In “Unusually Rewarding,” Calls For More Studies November 6, 1987
TCL Archive Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million. July 30, 2004
